JOSEPHSON NEIL enters IAMBIC THERAPEUTICS, INC. with 40.46K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/14/2026ACC: 0001864141-26-000005
Officer· Chief Medical Officer
Since Oct 2026
40.46K
Baseline shares
100% direct
40.46K
Direct ownership
1 position
232.58K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned40.46K
Total
40.46K direct40.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.46K | Direct |
| Total | 40.46K | 40.46K direct |
Derivative Holdings2
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
175.53K
Shares owned
N/A
Exercise price
4.95
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
57.05K
Shares owned
N/A
Exercise price
8.73
Expiration
—
Exercise window
—
Total
Underlying
232.58K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock | 4.95 | — | — | 175.53K | N/A |
| Employee Stock Option (right to buy) Direct | Common Stock | 8.73 | — | — | 57.05K | N/A |
| Total | 232.58K | 0.00 | ||||